PHK
IPXL

Point72 Hong Kong’s Impax Laboratories, Inc. IPXL Stock Holding History

Point72 Hong Kong’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,249
Closed -$46K – 1255
2017
Q3 		$46K Buy
2,249
+953
+74% +$18.2K 0.03% 264
2017
Q2 		$21K Sell
1,296
-522
-29% -$7.71K 0.02% 373
2017
Q1 		$23K Buy
1,818
+1,511
+492% +$18.3K 0.03% 385
2016
Q4 		$4K Buy
+307
New +$5.25K ﹤0.01% 743

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Point72 Hong Kong's IPXL Position: Q4 2017 in Review

Point72 Hong Kong sold out of Impax Laboratories, Inc. (IPXL) in Q4 2017, closing a stake of 2,249 shares — an estimated $46K sold.

Point72 Hong Kong first reported a position in IPXL in Q4 2016 and held it in 4 quarters. The position peaked at $46K in Q3 2017. 200 funds tracked by Wall St. Rank hold IPXL as of Q4 2017.

  • Point72 Hong Kong reported no remaining Impax Laboratories, Inc. position as of Q4 2017 after selling out during the quarter.
  • Point72 Hong Kong sold 2,249 Impax Laboratories, Inc. shares in Q4 2017, an estimated $46K.
  • Point72 Hong Kong first reported a position in Impax Laboratories, Inc. in Q4 2016 and held it in 4 quarters.
  • Point72 Hong Kong's Impax Laboratories, Inc. position peaked at $46K in Q3 2017.
  • 200 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2017.

Based on Point72 Hong Kong's 13F filing for Q4 2017, filed 14 Feb 2018.